Baxter International Inc. (BAX)

40,72 +0,32 (+0,79%) In data: 10:47AM EDT. Mercato aperto.

Baxter International Inc.

One Baxter Parkway
Deerfield, IL 60015
United States
224 948 2000
https://www.baxter.com

Settore/i: Healthcare
Settore: Medical Instruments & Supplies
Impiegati a tempo pieno: 60.000

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Jose E. Almeida	Chairman of the Board, President & CEO	3,62M	N/D	1962
Mr. Joel T. Grade	Executive VP & CFO	829,82k	N/D	1971
Ms. Heather Knight	Executive VP & Group President of Medical Products and Therapies	1,63M	N/D	1972
Mr. Alok Sonig B.E., Mba	Executive VP & Group President of Pharmaceuticals	1,56M	N/D	1972
Mr. Christopher A. Toth	Executive VP & Group President of Kidney Care	5,26M	N/D	1980
Ms. Tobi Karchmer M.D., M.S.	Senior VP and Chief Medical & Scientific Officer	N/D	N/D	N/D
Ms. Clare Trachtman	Vice President of Investor Relations	N/D	N/D	N/D
Mr. David S. Rosenbloom	Executive VP & General Counsel	776,51k	N/D	1960
Ms. Stacey Eisen	?Senior Vice President, Chief Communications Officer & Corporate Marketing?	N/D	N/D	N/D
Ms. Jeanne K. Mason Ph.D.	?Executive VP & Chief Human Resources Officer	1,99M	N/D	1956

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Governance aziendale

L'ISS Governance QualityScore di Baxter International Inc. al 1 aprile 2024 è 6. I criteri di valutazione fondamentali sono revisione: 6; Consiglio di Amministrazione: 6; diritti degli azionisti: 1; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.